Journal article
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
Abstract
BACKGROUND: The study objective was to determine the relative efficacy and safety of a low-molecular-weight heparinoid (Orgaran) compared with aspirin for the prevention of postoperative venous thromboembolism in patients undergoing surgery for fractured hips. A double-blind, randomized, controlled trial was used to study 251 consecutive eligible and consenting patients undergoing surgery for hip fracture in seven participating hospitals.
Authors
Gent M; Hirsh J; Ginsberg JS; Powers PJ; Levine MN; Geerts WH; Jay RM; Leclerc J; Neemeh JA; Turpie AGG
Journal
Circulation, Vol. 93, No. 1, pp. 80–84
Publisher
Wolters Kluwer
Publication Date
January 1996
DOI
10.1161/01.cir.93.1.80
ISSN
0009-7322